Tansuphasawadikul S, Pitisuttithum P, Knauer AD, Supanaranond W, Kaewkungwal J, Karmacharya BM, Chovavanich A. Clinical features, etiology and short term outcomes of interstitial pneumonitis in HIV/AIDS patients. Southeast Asia J Trop Med Public Health 2005:36Z6):1469-1478.
Knauer A, Das AK, Tansuphasawadikul S, supanaranond W, Pitisuttithum P, Wernsdorfer WH. Clinical features, aetiology and short-term outcomes of interstitial pneumonitis in HIV/AIDS patients at Bamrasnaradura Hospital, Nonthaburi, Thailand. Wien Klin Wochenschr 2005:117 Supplement 4:49-55.
Jenkins RA, Thapinta D, Morgan PA, Wongkamhaeng S, Sornsathapornkul P, Bussaratid V, Sontirat A, Pitisuttithum P, Thongchareoen P, Khamboonruang C, Suriyanon V, Nitayaphan S, Brown AE; Thai AIDS Vaccine Evaluation Group. Behavioral and social issues among volunteers in preventive HIV vaccine trial in Thailand. J Acquir Immune Defic Syndr 2005:15:40(5):592-599.
Dondorp AM, Desakorn V, Pongtavornpinyo W, Sahassananda D, Silamut K, Chotivanich K, Newton PN, Pitisuttithum P, Smithyman AM, White NJ, Day NP. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med 2005:2(8):e204.
Pitisuttithum P, Negroni R, Graybill JR, Bustamante B, Pappas P, Chapman S, Hare RS, Hardalo CJ. Activity of posaconazole in the treatment of central nervous system fungal infections. J Antimicrob Chemother 2005:56:745-755.
Tin EE, Bowonwatanuwong C, Desakorn V, Wilairatana P, Krudsood S, Pitisuttithum P. The efficacy and adverse effects of GPO-VIR (Stavudine+lamivudine+nevirapine) in treatment na?ve adult HIV patients. Southeast Asian J Trop Med Public Health 2005:36 (2):362-369.
Desakorn V, Dondorp AM, Silamut K, Pongtavornpinyo W, Sahassananda D, Chotivanich K, Pitisuttithum P, Smithyman AM, Day NP, White NJ. Stage dependent production and release of histidine-rich protein 2 by Plasmodium falciparum. Trans R Soc Trop Med Hyg 2005:99 (7):517-24.
Coplan PM, Gupta SB, Dubey SA, Pitisuttithum P, Nikas A, Mbewe B, Vardas E, Schechter M, Kallas EG, freed DC, fu TM, Mast CT, Puthavathana P, Kublin J, Brown Collins K, Chisi J, Pendame R, Thaler SJ, Gray G, McIntyre J, Straus WL, Condra JH, Mehrotra DV, Guess HA, Emini EA, Shiver JW. Cross-reactivity of anti-HIV-1 Tcell immune responses among the major HIV-1 Clades in HIV-1-Positive individuals from 4 continents. J Infect Dis 2005;191:1427-34.
Karnasuta C, paris RM, Cox JH, Nitayaphan S, Pitisuttithum P, Thongcharoen P, Brown AE, Gurunathan S, Tartaglia J, Heyward WL, McNeil JG, Birx DL, de Souza MS; Thai AIDS Vaccine Evaluation Group, Thailand. Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand. Vaccine 2005:23:2522-9.
Pitisutithum P. HIV-1 prophylactic vaccine trials in Thailand. Curr HIV Res 2005:3:17-30.
Pitisuttithum P, Berman PW, Phonrat B, et al. Phase I/II Study of a candidate vaccine designed against the B and E subtypes of HIV-1. J Acquire Immune Defic Syndr 2004:37:1160-1165.
Nitayaphan S, Pitisuttithum P, Karnasuta C, et al. Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults. J Infect Dis 2004:190:702-706.
Griensven FV, KeawKungwal J, Jordan W. Tappero, Sangkum U, Pitisuttithum P, Vanichseni S, Suntharasamai P, Orelind K, Carolyn Gee, Choopanya K for the Bangkok Vaccine Evaluation Group. Lack of increased HIV riskbehavior among infection drug users participating in the AIDSVAX B/E HIV vaccine trial, Bangkok, Thailand.AIDS 2004:18:295-301.
Paris R, Bejrachandra S, Karnasuta C, Chandanayingyong D, Kunachiwa W, Leetrakool N, Prakalapakorn S, Thongcharoen P, Nittayaphan S, Pitisuttithum P, Suriyanon V, Guruthan S, McNeil JG. Brown AE, Birx DL, de Souza M. HLA class I serotypes and cytotoxic T- lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp 120 or oligomeric gp 160 160 protein boosting. Tissue Antigens 2004:64:251-6.
Suphak Vanichseni, Jordan W. Tappero, Punnee Pitisuttithum, Dwip Kitayaporn, Timothy D. Mastro, Eiam Vimutisunthorn, Frits van Griensven, William L. Heyward, Donald P. Francis and Kachit Choopanya for the Bangkok Vaccine Evaluation Group. Recruitment, screening and characteristics of infection drug users participating in the AIDSVAX B/E HIV vaccine trial, Bangkok, Thailand.AIDS 2004 18:311-316.
Kim JH, Pitisuttithum P, Kamboonruang C, et al. Specific antibody responses to vaccination with bivalent CM 235/SI gp120: detection of homologous and heterogonous neutralizing antibody to subtype E(CRF 01.AE) HIV type 1. Res Hum Retroviruses 2003: 19:807-816.
Pitisuttithum P, Nitayaphan S, Thongcharoen P, et al. Safety and Immunogenicity of Combinations of Recombinant Subtype E and B HIV-1Envelope gp120 Vaccines in Healthy Thai Adults. J Infect Dis 2003: 188: 219-227.
Maek-A-Nantawat W, Pitisuttithum P, Phonrat B, et al. Evaluation of attitude, risk behavior and expectations among Thai participants in Phase I/II HIV/AIDS Vaccine Trials. J Med Assoc Thai 2003: 86: 299-307.
Maek-A-Nantawat W, Pitisuttithum P, Bussaratid V, et al. 6-month evaluation of JinHuang Chinese Herbal Medicine study in asymptomatic HIV infected Thai. Southeast Asian J Trop Med Public Health 2003:34:379-384.
Pitisuttithum P, Cohen MB, Phonrat B, Suthisarnsunton U, Bussaratid V, Desakorn V, Phumratanaprapin W, Singhasivanon P, Looareesuwan S, Schiff GM, Ivanoff B, Lang D. A Human volunteers challenge model using frozen bacteria of the new epidemic serotype, V.cholerae O139 in Thai volunteers. Vaccine 2002; 20:920-5.
Pukrittayakamee S, Pitisuttithum P, Zhang H, Jantra A, Wanwimolruk S, White NJ. Effects of cigarette smoking on quinine pharmacokinetics in malaria. Eur J Clin Pharmacol 2002; 58:315- 9.
Putong NM, Pitisuttithum P, Supanaranond W, Phonrat B, Tansuphasawadikul S, Silachamroon U, Yuda HC, Bussaratid V, Aswapokee N. Mycobacterium tuberculosis infection among HIV/AIDS patients in Thailand: clinical manifestations and outcomes. Southeast Asian J Trop Med Public Health 2002 ;33:346-51.
Bussaratid V, Tansupasawaskul S, Simpson A, Pitisuttithum P, Phonrat B, Howe P, White NJ. Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients.J Med Assoc Thai 2002; 85:757-64.
Desakorn V, Simpson AJ, Wuthiekanun V, Sahassananda D, Rajanuwong A, Pitisuttithum P, Howe PA, Smith MD, White NJ. Development and evaluation of rapid urinary antigen detection tests for diagnosis of penicillosis marneffei. J Clin Microbiol 2002; 40:3179-83.
Newton PN, Thai le H, Tip NQ, Short JM, Chierakul W, Rajanuwong A, Pitisuttithum P, Chasombat S , Phonrat B, Maek-A-Nantawat W,Teaunadi R, Lalloo DG, White NJ. A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis. Clin Infect Dis 2002; 35:769-72.
Thapinta D, Jenkins RA, Morgan PA, et al. Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in Thailand. J AcquirImmune Defic Syndr 2002: 30:503-513.
Pitisuttithum P, Nitayaphan S, M de Souza, et al. Live Recombinant ALVAC-HIV (vCP1521) Priming with AIDSVAX? B/E Boosting in Thailand: Safety & Immunogenicity (Abstract). 14th International AIDS Conference. Barcelona, Spain. July 7-12, 2002.
Pitisuttithum P, Tansuphasawadikul S, Simpson AJ, Howe PA, White NJ. A prospective study of AIDS-associated cryptococcal meningitis in Thailand: Treated with high-dose amphotericin B. J Infect 2001; 43:226-33.
Pitisuttithum P, The Bangkok Vaccine Evaluation Group. Thailands Success in Moving to the First Phase III HIV Vaccine Efficacy Trial in a Developing Country (Abstract). AIDS VACCINE 2001. Philadelphia, U.S.A., September 5-8, 2001 p144.
Pitisuttithum P, Nitayaphan S, Phonrat B, et al. Safety of Live Recombinant ALVACHIV (vCP1521) Priming with AIDSVAX? B/E Boosting in Thai HIV1 negative Participants: Preliminary Results (Abstract). 6th International Congress on AIDS in Asia and the Pacific. Melbourne, Australia. October 5-10, 2001.
Pitisuttithum P, Choopanya K, Phonrat B, Vanichseni S, Sangkum U, Heyward W, Gee C. for the Bangkok Vaccine Evaluation Group. The Conduct of Good Clinical Practices (GCP) in the First HIV-1 Vaccine Efficacy Trial in a Developing Country Bangkok, Thailand (Abstract). 6th International Congress on AIDS in Asia and the Pacific, Melbourne, Australia, Oct. 5-10, 2001.
Meak-A-Nantawat W, Pitisuttithum P, Phonrat B, Budsaratid V, Naksrisook S, Peonim W,Thantamnu N and Muanom R, Knowledge behavioral risk and psychological assessment of Thai volunteers participating in phase I/II HIV/AIDS vaccine trials. 6th International Congress on AIDS in Asia and the Pacific Melbourne, Australia, October 5 10, 2001.
Migasena S, Suntharasamai P, Pitisuttithum P, Kitayaporn D, Wasi C, Huang W, Vanichseni S, Koompong C, Kaewkungwal J, Raktham S, ppolito T, Hanson C, Gregory T, Heyward WL, Berman P, Francis D. AIDSVAX? (MN) in Bangkok injecting drug user: A report on safety and immunogenicity including mocrophage tropic virus neutralizing. AIDS Res Hum Retroviruses 2000; 16:655-63.
Pitisuttithum P, Phonrat B, Suntharasamai P, et al. Phase I/II Safety and Immunogenicity Trial of Bivalent rgp120 HIV Vaccine (AIDSVAX? B/E) in Bangkok, Thailand-Initial Report (Abstract). The Third Annual Conference on Vaccine Research. Washington DC, U.S.A. April 30-May 2, 2000. p.48.
Pitisuttithum P, Bangkok Vaccine Evaluation Group. Social harm monitoring among injecting drug users (IDUs) in a phase III HIV vaccine trial in Bangkok, Thailand-preliminary results. (Abstract). XII International AIDS Conference Durban, South Africa, 9-14 July 2000 p.443.
Pitisuttithum P, Phonrat B, Suntharasamai P, et al. Initial Report of a Phase I/II Safety and Immunogenicity Trial AIDSVAXTM? B/E rgp120 HIV Vaccine Bangkok, Thailand (Abstract). XII International AIDS Conference, Durban, South Africa, July 9-14, 2000.
